Vasselli JR, Shih JH, Iyengar SR, Maranchie J, Riss J, Worrell R, Torres-Cabala C, Tabios R, Mariotti A, Stearman R, et al: Predicting survival in patients with metastatic kidney cancer by gene-expression profiling in the primary tumor. Proc Natl Acad Sci USA. 2003, 100 (12): 6958-6963. 10.1073/pnas.1131754100.
Article
PubMed Central
CAS
PubMed
Google Scholar
van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, et al: A gene-expression signature as a predictor of survival in breast cancer. The New England journal of medicine. 2002, 347 (25): 1999-2009. 10.1056/NEJMoa021967.
Article
CAS
PubMed
Google Scholar
van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, et al: Gene expression profiling predicts clinical outcome of breast cancer. Nature. 2002, 415 (6871): 530-536. 10.1038/415530a.
Article
PubMed
Google Scholar
West M, Blanchette C, Dressman H, Huang E, Ishida S, Spang R, Zuzan H, Olson JA, Marks JR, Nevins JR: Predicting the clinical status of human breast cancer by using gene expression profiles. Proc Natl Acad Sci USA. 2001, 98 (20): 11462-11467. 10.1073/pnas.201162998.
Article
PubMed Central
CAS
PubMed
Google Scholar
Lawrie CH, Chi J, Taylor S, Tramonti D, Ballabio E, Palazzo S, Saunders NJ, Pezzella F, Boultwood J, Wainscoat JS, et al: Expression of microRNAs in diffuse large B cell lymphoma is associated with immunophenotype, survival and transformation from follicular lymphoma. Journal of cellular and molecular medicine. 2009, 13 (7): 1248-1260. 10.1111/j.1582-4934.2008.00628.x.
Article
PubMed Central
CAS
PubMed
Google Scholar
Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, Pulford K, Banham AH, Pezzella F, Boultwood J, Wainscoat JS, et al: Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. British journal of haematology. 2008, 141 (5): 672-675. 10.1111/j.1365-2141.2008.07077.x.
Article
PubMed
Google Scholar
Lawrie CH, Soneji S, Marafioti T, Cooper CD, Palazzo S, Paterson JC, Cattan H, Enver T, Mager R, Boultwood J, et al: MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma. International journal of cancer Journal international du cancer. 2007, 121 (5): 1156-1161. 10.1002/ijc.22800.
Article
CAS
PubMed
Google Scholar
Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, et al: MicroRNA gene expression deregulation in human breast cancer. Cancer research. 2005, 65 (16): 7065-7070. 10.1158/0008-5472.CAN-05-1783.
Article
CAS
PubMed
Google Scholar
Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE, Iorio MV, Visone R, Sever NI, Fabbri M, et al: A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. The New England journal of medicine. 2005, 353 (17): 1793-1801. 10.1056/NEJMoa050995.
Article
CAS
PubMed
Google Scholar
Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y, et al: Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer research. 2004, 64 (11): 3753-3756. 10.1158/0008-5472.CAN-04-0637.
Article
CAS
PubMed
Google Scholar
Bartel DP, MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004, 116 (2): 281-297. 10.1016/S0092-8674(04)00045-5.
Article
CAS
PubMed
Google Scholar
Volinia S, Croce CM: Prognostic microRNA/mRNA signature from the integrated analysis of patients with invasive breast cancer. Proc Natl Acad Sci USA. 2013, 110 (18): 7413-7417. 10.1073/pnas.1304977110.
Article
PubMed Central
CAS
PubMed
Google Scholar
Buffa FM, Camps C, Winchester L, Snell CE, Gee HE, Sheldon H, Taylor M, Harris AL, Ragoussis J: microRNA-associated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancer. Cancer research. 2011, 71 (17): 5635-5645. 10.1158/0008-5472.CAN-11-0489.
Article
CAS
PubMed
Google Scholar
Gade S, Porzelius C, Falth M, Brase JC, Wuttig D, Kuner R, Binder H, Sultmann H, Beissbarth T: Graph based fusion of miRNA and mRNA expression data improves clinical outcome prediction in prostate cancer. BMC Bioinformatics. 2011, 12: 488-10.1186/1471-2105-12-488.
Article
PubMed Central
CAS
PubMed
Google Scholar
Creighton CJ, Hernandez-Herrera A, Jacobsen A, Levine DA, Mankoo P, Schultz N, Du Y, Zhang Y, Larsson E, Sheridan R, et al: Integrated analyses of microRNAs demonstrate their widespread influence on gene expression in high-grade serous ovarian carcinoma. PLoS One. 2012, 7 (3): e34546-10.1371/journal.pone.0034546.
Article
PubMed Central
CAS
PubMed
Google Scholar
Enerly E, Steinfeld I, Kleivi K, Leivonen SK, Aure MR, Russnes HG, Ronneberg JA, Johnsen H, Navon R, Rodland E, et al: miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors. PLoS One. 2011, 6 (2): e16915-10.1371/journal.pone.0016915.
Article
PubMed Central
CAS
PubMed
Google Scholar
Bair E, Tibshirani R: Semi-supervised methods to predict patient survival from gene expression data. PLoS biology. 2004, 2 (4): E108-10.1371/journal.pbio.0020108.
Article
PubMed Central
PubMed
Google Scholar
TCGA Network: Integrated genomic analyses of ovarian carcinoma. Nature. 2011, 474 (7353): 609-615. 10.1038/nature10166.
Article
Google Scholar
Kim D, Shin H, Song YS, Kim JH: Synergistic effect of different levels of genomic data for cancer clinical outcome prediction. J Biomed Inform. 2012, 45 (6): 1191-1198. 10.1016/j.jbi.2012.07.008.
Article
CAS
PubMed
Google Scholar
Vergoulis T, Vlachos IS, Alexiou P, Georgakilas G, Maragkakis M, Reczko M, Gerangelos S, Koziris N, Dalamagas T, Hatzigeorgiou AG: TarBase 6.0: capturing the exponential growth of miRNA targets with experimental support. Nucleic acids research. 2012, 40 (Database): D222-229.
Article
PubMed Central
CAS
PubMed
Google Scholar
Zhou X, Zhao F, Wang ZN, Song YX, Chang H, Chiang Y, Xu HM: Altered expression of miR-152 and miR-148a in ovarian cancer is related to cell proliferation. Oncology reports. 2012, 27 (2): 447-454.
CAS
PubMed
Google Scholar
Delfino KR, Rodriguez-Zas SL: Transcription factor-microRNA-target gene networks associated with ovarian cancer survival and recurrence. PLoS One. 2013, 8 (3): e58608-10.1371/journal.pone.0058608.
Article
PubMed Central
CAS
PubMed
Google Scholar
Chang H, Zhou X, Wang ZN, Song YX, Zhao F, Gao P, Chiang Y, Xu HM: Increased expression of miR-148b in ovarian carcinoma and its clinical significance. Molecular medicine reports. 2012, 5 (5): 1277-1280.
CAS
PubMed
Google Scholar
Furuta M, Kozaki KI, Tanaka S, Arii S, Imoto I, Inazawa J: miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis. 2010, 31 (5): 766-776. 10.1093/carcin/bgp250.
Article
CAS
PubMed
Google Scholar
Dalmay T, Edwards DR: MicroRNAs and the hallmarks of cancer. Oncogene. 2006, 25 (46): 6170-6175. 10.1038/sj.onc.1209911.
Article
CAS
PubMed
Google Scholar
Lui WO, Pourmand N, Patterson BK, Fire A: Patterns of known and novel small RNAs in human cervical cancer. Cancer research. 2007, 67 (13): 6031-6043. 10.1158/0008-5472.CAN-06-0561.
Article
CAS
PubMed
Google Scholar
Hoffman AE, Zheng T, Yi C, Leaderer D, Weidhaas J, Slack F, Zhang Y, Paranjape T, Zhu Y: microRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis. Cancer research. 2009, 69 (14): 5970-5977. 10.1158/0008-5472.CAN-09-0236.
Article
PubMed Central
CAS
PubMed
Google Scholar
Abdollahi A, Pisarcik D, Roberts D, Weinstein J, Cairns P, Hamilton TC: LOT1 (PLAGL1/ZAC1), the candidate tumor suppressor gene at chromosome 6q24-25, is epigenetically regulated in cancer. The Journal of biological chemistry. 2003, 278 (8): 6041-6049. 10.1074/jbc.M210361200.
Article
CAS
PubMed
Google Scholar
Xiao J, Chen JX, Zhu YP, Zhou LY, Shu QA, Chen LW: Reduced expression of MTUS1 mRNA is correlated with poor prognosis in bladder cancer. Oncology letters. 2012, 4 (1): 113-118.
PubMed Central
CAS
PubMed
Google Scholar
Califano D, Pignata S, Pisano C, Greggi S, Laurelli G, Losito NS, Ottaiano A, Gallipoli A, Pasquinelli R, De Simone V, et al: FEZ1/LZTS1 protein expression in ovarian cancer. Journal of cellular physiology. 2010, 222 (2): 382-386. 10.1002/jcp.21962.
Article
CAS
PubMed
Google Scholar
Yao JJ, Liu Y, Lacorazza HD, Soslow RA, Scandura JM, Nimer SD, Hedvat CV: Tumor promoting properties of the ETS protein MEF in ovarian cancer. Oncogene. 2007, 26 (27): 4032-4037. 10.1038/sj.onc.1210170.
Article
CAS
PubMed
Google Scholar
Duncan TJ, Rolland P, Deen S, Scott IV, Liu DT, Spendlove I, Durrant LG: Loss of IFN gamma receptor is an independent prognostic factor in ovarian cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2007, 13 (14): 4139-4145. 10.1158/1078-0432.CCR-06-2833.
Article
CAS
Google Scholar
Li Y, Guessous F, Zhang Y, Dipierro C, Kefas B, Johnson E, Marcinkiewicz L, Jiang J, Yang Y, Schmittgen TD, et al: MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. Cancer Res. 2009, 69 (19): 7569-7576. 10.1158/0008-5472.CAN-09-0529.
Article
PubMed Central
CAS
PubMed
Google Scholar
Zhao S, Yang G, Mu Y, Han D, Shi C, Chen X, Deng Y, Zhang D, Wang L, Liu Y, et al: MiR-106a is an independent prognostic marker in patients with glioblastoma. Neuro Oncol. 2013, 15 (6): 707-717. 10.1093/neuonc/not001.
Article
PubMed Central
CAS
PubMed
Google Scholar
Zhang C, Kang C, You Y, Pu P, Yang W, Zhao P, Wang G, Zhang A, Jia Z, Han L, et al: Co-suppression of miR-221/222 cluster suppresses human glioma cell growth by targeting p27kip1 in vitro and in vivo. Int J Oncol. 2009, 34 (6): 1653-1660.
CAS
PubMed
Google Scholar
Wu N, Zhao X, Liu M, Liu H, Yao W, Zhang Y, Cao S, Lin X: Role of microRNA-26b in glioma development and its mediated regulation on EphA2. PLoS One. 2011, 6 (1): e16264-10.1371/journal.pone.0016264.
Article
PubMed Central
CAS
PubMed
Google Scholar
Lu S, Wang S, Geng S, Ma S, Liang Z, Jiao B: Increased expression of microRNA-17 predicts poor prognosis in human glioma. J Biomed Biotechnol. 2012, 2012: 970761-
PubMed Central
PubMed
Google Scholar
Ernst A, Hofmann S, Ahmadi R, Becker N, Korshunov A, Engel F, Hartmann C, Felsberg J, Sabel M, Peterziel H, et al: Genomic and expression profiling of glioblastoma stem cell-like spheroid cultures identifies novel tumor-relevant genes associated with survival. Clin Cancer Res. 2009, 15 (21): 6541-6550. 10.1158/1078-0432.CCR-09-0695.
Article
CAS
PubMed
Google Scholar
Lubin M, Lubin A: Selective killing of tumors deficient in methylthioadenosine phosphorylase: a novel strategy. PLoS One. 2009, 4 (5): e5735-10.1371/journal.pone.0005735.
Article
PubMed Central
PubMed
Google Scholar
Nobusawa S, Stawski R, Kim YH, Nakazato Y, Ohgaki H: Amplification of the PDGFRA, KIT and KDR genes in glioblastoma: a population-based study. Neuropathology. 2011, 31 (6): 583-588. 10.1111/j.1440-1789.2011.01204.x.
Article
PubMed
Google Scholar
Tribius S, Pidel A, Casper D: ATM protein expression correlates with radioresistance in primary glioblastoma cells in culture. Int J Radiat Oncol Biol Phys. 2001, 50 (2): 511-523. 10.1016/S0360-3016(01)01489-4.
Article
CAS
PubMed
Google Scholar